Literature DB >> 33670390

Differences in the Central Energy Metabolism of Cancer Cells between Conventional 2D and Novel 3D Culture Systems.

Ryo Ikari1, Ken-Ichi Mukaisho2, Susumu Kageyama1, Masayuki Nagasawa1, Shigehisa Kubota1, Takahisa Nakayama2, Shoko Murakami3, Naoko Taniura2, Hiroyuki Tanaka4, Ryoji P Kushima2, Akihiro Kawauchi1.   

Abstract

The conventional two-dimensional (2D) culture is available as an in vitro experimental model. However, the culture system reportedly does not recapitulate the in vivo cancer microenvironment. We recently developed a tissueoid cell culture system using Cellbed, which resembles the loose connective tissue in living organisms. The present study performed 2D and three-dimensional (3D) culture using prostate and bladder cancer cell lines and a comprehensive metabolome analysis. Compared to 3D, the 2D culture had significantly lower levels of most metabolites. The 3D culture system did not impair mitochondrial function in the cancer cells and produce energy through the mitochondria simultaneously with aerobic glycolysis. Conversely, ATP production, biomass (nucleotides, amino acids, lipids and NADPH) synthesis and redox balance maintenance were conducted in 3D culture. In contrast, in 2D culture, biomass production was delayed due to the suppression of metabolic activity. The 3D metabolome analysis using the tissueoid cell culture system capable of in vivo cancer cell culture yielded results consistent with previously reported cancer metabolism theories. This system is expected to be an essential experimental tool in a wide range of cancer research fields, especially in preclinical stages while transitioning from in vitro to in vivo.

Entities:  

Keywords:  cancer metabolism; prostate cancer; three-dimensional; tissueoid cell culture system; urinary bladder cancer

Mesh:

Year:  2021        PMID: 33670390      PMCID: PMC7917672          DOI: 10.3390/ijms22041805

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  35 in total

Review 1.  Can the pharmaceutical industry reduce attrition rates?

Authors:  Ismail Kola; John Landis
Journal:  Nat Rev Drug Discov       Date:  2004-08       Impact factor: 84.694

2.  Trial watch: phase II and phase III attrition rates 2011-2012.

Authors:  John Arrowsmith; Philip Miller
Journal:  Nat Rev Drug Discov       Date:  2013-08       Impact factor: 84.694

3.  Trial watch: Phase II failures: 2008-2010.

Authors:  John Arrowsmith
Journal:  Nat Rev Drug Discov       Date:  2011-05       Impact factor: 84.694

4.  Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity.

Authors:  Frank Weinberg; Robert Hamanaka; William W Wheaton; Samuel Weinberg; Joy Joseph; Marcos Lopez; Balaraman Kalyanaraman; Gökhan M Mutlu; G R Scott Budinger; Navdeep S Chandel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

5.  Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

Authors:  M E Kaighn; K S Narayan; Y Ohnuki; J F Lechner; L W Jones
Journal:  Invest Urol       Date:  1979-07

6.  Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling.

Authors:  Chendong Yang; Jessica Sudderth; Tuyen Dang; Robert M Bachoo; Robert G Bachoo; Jeffrey G McDonald; Ralph J DeBerardinis
Journal:  Cancer Res       Date:  2009-10-13       Impact factor: 12.701

Review 7.  Metabolic signatures of cancer cells and stem cells.

Authors:  Andrew M Intlekofer; Lydia W S Finley
Journal:  Nat Metab       Date:  2019-02-11

8.  Metabolomics analysis reveals distinct profiles of nonmuscle-invasive and muscle-invasive bladder cancer.

Authors:  Divya Sahu; Yair Lotan; Bryan Wittmann; Bruce Neri; Donna E Hansel
Journal:  Cancer Med       Date:  2017-08-01       Impact factor: 4.452

9.  Stable Isotope-Resolved Metabolomics Shows Metabolic Resistance to Anti-Cancer Selenite in 3D Spheroids versus 2D Cell Cultures.

Authors:  Teresa W-M Fan; Salim S El-Amouri; Jessica K A Macedo; Qing Jun Wang; Huan Song; Teresa Cassel; Andrew N Lane
Journal:  Metabolites       Date:  2018-07-10

10.  Similarities and differences in metabolites of tongue cancer cells among two- and three-dimensional cultures and xenografts.

Authors:  Shoko Murakami; Hiroyuki Tanaka; Takahisa Nakayama; Naoko Taniura; Toru Miyake; Masaji Tani; Ryoji Kushima; Gaku Yamamoto; Hiroyuki Sugihara; Ken-Ichi Mukaisho
Journal:  Cancer Sci       Date:  2020-12-26       Impact factor: 6.716

View more
  4 in total

Review 1.  Research and Development of Microphysiological Systems in Japan Supported by the AMED-MPS Project.

Authors:  Seiichi Ishida
Journal:  Front Toxicol       Date:  2021-04-29

2.  Flavonoids Enhance Lipofection Efficiency and Ameliorate Cytotoxicity in Colon26 and HepG2 Cells via Oxidative Stress Regulation.

Authors:  Die Hu; Shintaro Fumoto; Hirotaka Miyamoto; Masakazu Tanaka; Koyo Nishida
Journal:  Pharmaceutics       Date:  2022-06-05       Impact factor: 6.525

3.  Physiological Media in Studies of Cell Metabolism.

Authors:  M V Golikov; V T Valuev-Elliston; O A Smirnova; A V Ivanov
Journal:  Mol Biol       Date:  2022-10-05       Impact factor: 1.540

4.  Cultivation of Cells in a Physiological Plasmax Medium Increases Mitochondrial Respiratory Capacity and Reduces Replication Levels of RNA Viruses.

Authors:  Michail V Golikov; Inna L Karpenko; Anastasiya V Lipatova; Olga N Ivanova; Irina T Fedyakina; Viktor F Larichev; Natalia F Zakirova; Olga G Leonova; Vladimir I Popenko; Birke Bartosch; Sergey N Kochetkov; Olga A Smirnova; Alexander V Ivanov
Journal:  Antioxidants (Basel)       Date:  2021-12-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.